Melissa Hartley

Lopinavir-ritonavir and hydroxychloroquine for critically ill patients with COVID-19: REMAP-CAP randomized controlled trial

Matthew A. Wiles, Manisha, Christopher M. Horvat, 2021, Intensive Care Medicine.

Long-term (180-Day) Outcomes in Critically Ill Patients With COVID-19 in the REMAP-CAP Randomized Clinical Trial.

Matthew A. Wiles, Nerissa C. Brown, Christopher M. Horvat, 2022, JAMA.

Investigation of pegloticase-associated adverse events from a nationwide reporting system database.

M. Bottorff, P. Gandhi, W. M. Gentry, 2014, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

A Novel Pulsed Stimulation Pattern in Spinal Cord Stimulation: Clinical Results and Postulated Mechanisms of Action in the Treatment of Chronic Low Back and Leg Pain.

P. Staats, N. Patel, Nicholas P Sullivan, 2022, Neuromodulation : journal of the International Neuromodulation Society.